SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma

NCT01362790 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

NIH

Sponsor class

Conditions

Mesothelioma
Adenocarcinoma of Lung
Pancreatic Neoplasms

Interventions

DRUG: Pentostatin
DRUG: Cyclophosphamide
BIOLOGICAL: SS1(dsFv)PE38 - lot 073I0809
BIOLOGICAL: SS1(dsFv)PE38 - lot FIL129J01

Sponsor

National Cancer Institute (NCI)